Results for tag: "Calaspargase Pegol"

Calaspargase Pegol (CPG) is a drug used in oncology to treat acute lymphoblastic leukemia (ALL). It is a pegylated form of the enzyme asparaginase, which is used to reduce the levels of asparagine in the body. CPG is administered intravenously and is used in combination with other chemotherapy drugs to treat ALL. CPG works by breaking down asparagine, an amino acid that is essential for the growth of cancer cells. By reducing the levels of asparagine, CPG helps to slow the growth of cancer cells and can help to reduce the side effects of chemotherapy. CPG is a relatively new drug and is still in the early stages of development. It is currently approved for use in the United States and Europe, and is being studied in other countries. Several companies are involved in the development and marketing of CPG, including Pfizer, Merck, and Novartis. Show Less Read more